Browse All

Current Filters

CLEAR FILTER x

TITLE

Continued Evaluation of Safety, Tolerability, and Clinical Outcomes in Participants with Parkinson’s Disease Throughout Three Years After Bemdaneprocel Administration

exPDite-2: A Phase Three, Randomized, Sham-controlled, Double-blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease